Job title: Director of Scientific Engagement
Dr Fred Beasley is the Director of Scientific Engagement for the Cardiovascular and Metabolic Disease Division at Crown Bioscience, where he uses his training in animal model development and direction to assist in study design and client/operations communications.
Prior to joining CrownBio, Fred served as in vivo biologist at the NASH/inflammation startup Jecure Therapeutics (acquired by Genentech in 2018); and as a Study Director at BTS Research, southern California’s sole CRO provider of preclinical NHP models.
Fred obtained his PhD in Microbiology and Immunology at the University of Western Ontario, and completed postdoctoral training at UC San Diego and at Calibr/Scripps Research Institute. His research efforts focused on developing rodent models to evaluate small molecule drugs against bacterial and parasitic pathogens, and he is an author on over 20 publications.